These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35043007)

  • 1. Tumour-infiltrating lymphocytes in oropharyngeal cancer: a validation study according to the criteria of the International Immuno-Oncology Biomarker Working Group.
    Almangush A; Jouhi L; Atula T; Haglund C; Mäkitie AA; Hagström J; Leivo I
    Br J Cancer; 2022 Jun; 126(11):1589-1594. PubMed ID: 35043007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour infiltrating lymphocytes in oropharyngeal carcinoma: prognostic value and evaluation of a standardised method.
    De Keukeleire SJ; Vermassen T; De Meulenaere A; Deron P; Huvenne W; Duprez F; Creytens D; Van Dorpe J; Rottey S; Ferdinande L
    Pathology; 2021 Dec; 53(7):836-843. PubMed ID: 34217516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of tumour-infiltrating lymphocytes as a prognostic factor in patients with human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    Ruangritchankul K; Sandison A; Warburton F; Guerrero-Urbano T; Reis Ferreira M; Lei M; Thavaraj S
    Histopathology; 2019 Jul; 75(1):146-150. PubMed ID: 31144335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of overall assessment of tumor-infiltrating lymphocytes in oropharyngeal cancer: A meta-analysis.
    Almangush A; Alabi RO; De Keukeleire S; Mäkitie AA; Pirinen M; Leivo I
    Pathol Res Pract; 2023 Mar; 243():154342. PubMed ID: 36758415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-infiltrating lymphocytes in oral cavity squamous cell carcinoma and its association with clinicopathological parameters.
    Ahuja S; Khan AA; Zaheer S; Ranga S
    Pathol Res Pract; 2023 Nov; 251():154882. PubMed ID: 37898039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Imaging Biomarker of Tumor-Infiltrating Lymphocytes to Risk-Stratify Patients With HPV-Associated Oropharyngeal Cancer.
    Corredor G; Toro P; Koyuncu C; Lu C; Buzzy C; Bera K; Fu P; Mehrad M; Ely KA; Mokhtari M; Yang K; Chute D; Adelstein DJ; Thompson LDR; Bishop JA; Faraji F; Thorstad W; Castro P; Sandulache V; Koyfman SA; Lewis JS; Madabhushi A
    J Natl Cancer Inst; 2022 Apr; 114(4):609-617. PubMed ID: 34850048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overall assessment of tumor-infiltrating lymphocytes in head and neck squamous cell carcinoma: time to take notice.
    Almangush A; Leivo I; Mäkitie AA
    Acta Otolaryngol; 2020 Mar; 140(3):246-248. PubMed ID: 32022615
    [No Abstract]   [Full Text] [Related]  

  • 8. Liprin-α1 Expression in Tumor-Infiltrating Lymphocytes Associates with Improved Survival in Patients with HPV-Positive Oropharyngeal Squamous Cell Carcinoma.
    Sjöblom A; Pehkonen H; Jouhi L; Monni O; Randén-Brady R; Karhemo PR; Tarkkanen J; Haglund C; Mattila P; Mäkitie A; Hagström J; Carpén T
    Head Neck Pathol; 2023 Sep; 17(3):647-657. PubMed ID: 37335526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PD-L1 Expression and a High Tumor Infiltrate of CD8+ Lymphocytes Predict Outcome in Patients with Oropharyngeal Squamous Cells Carcinoma.
    Wuerdemann N; Gültekin SE; Pütz K; Wittekindt C; Huebbers CU; Sharma SJ; Eckel H; Schubotz AB; Gattenlöhner S; Büttner R; Speel EJ; Klussmann JP; Wagner S; Quaas A
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32718057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD8+ tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre study of the German cancer consortium radiation oncology group (DKTK-ROG).
    Balermpas P; Rödel F; Rödel C; Krause M; Linge A; Lohaus F; Baumann M; Tinhofer I; Budach V; Gkika E; Stuschke M; Avlar M; Grosu AL; Abdollahi A; Debus J; Bayer C; Stangl S; Belka C; Pigorsch S; Multhoff G; Combs SE; Mönnich D; Zips D; Fokas E
    Int J Cancer; 2016 Jan; 138(1):171-81. PubMed ID: 26178914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic markers in oropharyngeal squamous cell carcinoma: focus on CD70 and tumour infiltrating lymphocytes.
    De Meulenaere A; Vermassen T; Aspeslagh S; Zwaenepoel K; Deron P; Duprez F; Rottey S; Ferdinande L
    Pathology; 2017 Jun; 49(4):397-404. PubMed ID: 28427753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Tumor-Infiltrating Lymphocytes on Disease Progression in Human Papillomavirus-Related Oropharyngeal Carcinoma.
    Yin LX; Rivera M; Garcia JJ; Bartemes KR; Lewis DB; Lohse CM; Routman DM; Ma DJ; Moore EJ; Van Abel KM
    Otolaryngol Head Neck Surg; 2023 Sep; 169(3):539-547. PubMed ID: 36939471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-treatment absolute lymphocyte count predicts for improved survival in human papillomavirus (HPV)-driven oropharyngeal squamous cell carcinoma.
    Kreinbrink PJ; Li J; Parajuli S; Wise-Draper TM; Choi DL; Tang AL; Takiar V
    Oral Oncol; 2021 May; 116():105245. PubMed ID: 33901866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Tumor-infiltrating Lymphocytes Predicts the Behavior of Early-stage Oral Tongue Cancer.
    Heikkinen I; Bello IO; Wahab A; Hagström J; Haglund C; Coletta RD; Nieminen P; Mäkitie AA; Salo T; Leivo I; Almangush A
    Am J Surg Pathol; 2019 Oct; 43(10):1392-1396. PubMed ID: 31290758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant association of PD-L1 expression with human papillomavirus positivity and its prognostic impact in oropharyngeal cancer.
    Hong AM; Ferguson P; Dodds T; Jones D; Li M; Yang J; Scolyer RA
    Oral Oncol; 2019 May; 92():33-39. PubMed ID: 31010620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A digital score of tumour-associated stroma infiltrating lymphocytes predicts survival in head and neck squamous cell carcinoma.
    Shaban M; Raza SEA; Hassan M; Jamshed A; Mushtaq S; Loya A; Batis N; Brooks J; Nankivell P; Sharma N; Robinson M; Mehanna H; Khurram SA; Rajpoot N
    J Pathol; 2022 Feb; 256(2):174-185. PubMed ID: 34698394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma.
    Oguejiofor KK; Hall JS; Mani N; Douglas C; Slevin NJ; Homer J; Hall G; West CM
    Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):630-8. PubMed ID: 23916365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tumor immune microenvironment and its implications for clinical outcome in patients with oropharyngeal squamous cell carcinoma.
    Gurin D; Slavik M; Hermanova M; Selingerova I; Kazda T; Hendrych M; Shatokhina T; Vesela M
    J Oral Pathol Med; 2020 Oct; 49(9):886-896. PubMed ID: 32516834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
    Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
    Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor Infiltrating Lymphocytes are Prognostic Factors and Can Be Markers of Sensitivity to Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma.
    Suzuki H; Kawasaki Y; Miura M; Hatakeyama H; Shina K; Suzuki S; Yamada T; Suzuki M; Ito A; Omori Y
    Asian Pac J Cancer Prev; 2022 Apr; 23(4):1271-1278. PubMed ID: 35485685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.